Martin Shkreli, the notorious pharma chief finds himself in hot water yet again. Not for purchasing the Wu-Tang Clan's unreleased album for $2 million but this time for securities fraud at his former company Retrophin.
Read MoreThe merger frenzy in healthcare continues. In a deal that highlights tax inversion techniques, Pfizer and Allergen have announced a $160 billion merger. This deal creates the worlds largest drugmaker with high-profile products such as Botox, Lipitor and Viagra.
Read MoreAccording to a Reuters report Pfizer and Allergan are in friendly but early talks to become the world's largest drugmaker. Allergan shares jumped 6.4 percent to $305.46 in U.S. trading, while Pfizer was off 2.7 percent at $34.51.
Read MoreLast month we reported on how Martin Shkreli increased the cost of a critical drug called Daraprim by 5000%. Well, Imprimis Pharmaceuticals announced yesterday that they will be providing a customizable formulation to compete with Daraprim, a drug used to treat a parasitic infection called toxoplasmosis in people with compromised immune systems according to Business Insider.
Read MoreMartin Shkreli, the embattled CEO of Turing Pharmaceuticals announced that his company will reverse course and not raise the price on a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
Read More
© 2013-2015 Copyright, MedicalGroups.com, Rational Actors Society Inc. All Rights Reserved
Medical Groups
Rational Actors Society Inc.
260 NEWPORT CENTER DRIVE STE. 210
NEWPORT BEACH, CA 92660
Site design by Experiencia Social
